Market Cap

Cencora, Inc. Market Capitalization:

$65.71 Billion

USD as of Jan. 1, 2026

business Cencora, Inc. Company Profile

Cencora, Inc. Main Stock Listing

NYSE: COR

Market Capitalization History of Cencora, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Distribution
Company Market Cap (USD)
McKesson Corporation $102.42 B
Cardinal Health, Inc. $48.88 B
Shanghai Pharmaceuticals Holding Co. Ltd $9.44 B
Henry Schein, Inc. $9.32 B
Sinopharm Group Co. Ltd $8.03 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Cencora, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $65.71 B 37.13%
Jan. 1, 2025 $47.92 B 10.39%
Jan. 1, 2024 $43.41 B 29.63%
Jan. 1, 2023 $33.49 B 24.05%
Jan. 1, 2022 $26.99 B 30.71%
Jan. 1, 2021 $20.65 B 21.79%
Jan. 1, 2020 $16.96 B 2.63%
Jan. 1, 2019 $16.52 B -16.35%
Jan. 1, 2018 $19.75 B 14.20%
Jan. 1, 2017 $17.30 B -2.55%
Jan. 1, 2016 $17.75 B -5.78%
Jan. 1, 2015 $18.84 B 41.40%
Jan. 1, 2014 $13.32 B 48.16%
Jan. 1, 2013 $8.99 B 16.42%
Jan. 1, 2012 $7.72 B 8.67%
Jan. 1, 2011 $7.11 B 31.55%
Jan. 1, 2010 $5.40 B 50.11%
Jan. 1, 2009 $3.60 B -22.03%
Jan. 1, 2008 $4.62 B -8.34%
Jan. 1, 2007 $5.04 B 20.03%
Jan. 1, 2006 $4.20 B 49.72%
Jan. 1, 2005 $2.80 B 5.92%
Jan. 1, 2004 $2.65 B -5.45%
Jan. 1, 2003 $2.80 B -10.06%
Jan. 1, 2002 $3.11 B 35.34%
Jan. 1, 2001 $2.30 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Cencora, Inc. Categories

United States languages Healthcare languages Medical Distribution
United States Healthcare United States Medical Distribution

Stocks & Indices

Cencora, Inc. has the following listings and related stock indices.


Stock: NYSE: COR

Stock: FSX: ABG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.